Search
Search Results
##search.searchResults.foundPlural##
-
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3404PDF: 1299HTML: 2230Fi.1 Gritti.Rambaldi: 210 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1422PDF: 829HTML: 3124 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3818PDF: 1683HTML: 11633Figures Haase: 207 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3793PDF: 1602HTML: 500Figures . Eliassian: 229 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2285PDF: 897HTML: 2006Fig 1 Rossi: 185 -
Severe eosinophilia in a case of giardiasis
1082PDF: 1579HTML: 430 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2781PDF: 980HTML: 4709 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1646PDF: 595HTML: 235 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4032PDF: 1535HTML: 9192Untitled: 284Untitled: 192Untitled: 176Untitled: 170Untitled: 194Untitled: 348 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3590PDF: 2515HTML: 1499 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2882PDF: 858HTML: 6533Untitled: 237Untitled: 200Untitled: 212Untitled: 225 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4823PDF: 2871HTML: 2311 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1207PDF: 747Html: 102 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1421PDF: 1327HTML: 101 -
-
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3270PDF: 1353HTML: 4144 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4359PDF: 1529HTML: 1559Untitled: 240 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2838PDF: 1020HTML: 5526 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1321PDF: 1100PDF: 890HTML: 178 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1516PDF: 1087HTML: 223 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3312PDF: 951HTML: 2966 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277698PDF: 1811HTML: 3875 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1193PDF: 607HTML: 6804 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1323PDF: 1023HTML: 125 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1732PDF: 1204HTML: 235







